Accessibility

Conduct comparative analyses across multiple sample formats with Discovery’s unrivaled inventory of patient and time-matched samples.

Quality

Purchase with confidence from our ethically collected and hyper-annotated™ matched biospecimens inventory.

Expertise

Engage with our biospecimens and biomarker specialists regarding sample utilization questions or for biomarker discovery and validation services that can streamline your oncology R&D.

Find The Support Your Project Needs With Discovery’s Extensive Range of High-Quality Matched Sample Sets

Available Matched Sets

FFPE Matched Sets

FFPE
  • Full FFPE block
  • Samples from X oncology indications
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Plasma
  • Pathology report and clinical information
Buffy Coat
  • Pathology report and clinical information
FFPE
  • Full FFPE block
  • Samples from X oncology indications
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resection date, tumor percentage, etc
DTCs
  • Cell population analysis and HLA-A02 typing by flow cytometry
  • Pathology report and clinical information
  • Mutation/biomarker tested patient samples
FFPE
  • Full FFPE block
  • Samples from 10 oncology indications
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Flash Frozen Tissue
  • More than 175mg of flash-frozen tissue
SpecimenSeq™ FFPE
  • NGS-characterized samples from 15 indications and 273 unique patients
  • HAD QGEN MultiModal service with Qiagen Clinical Insights (QCI) report
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resection date, tumor percentage, etc.
Plasma
  • Pathology report and clinical information

DTCs Matched Sets

DTCs
  • Tumor microenvironment analysis and HLA-A02 typing by flow cytometry
  • Mutation/biomarker tested patient samples
  • PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
PBMCs
  • Cell counts and viability using AOPI staining
  • Pathology report and clinical information
DTCs
  • Cell population analysis and HLA-A02 typing by flow cytometry
  • Mutation/biomarker tested patient samples
  • PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
FFPE
  • Full FFPE block
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resectiond date, tumor percentage, etc.
DTCs
  • Cell population analysis and HLA-A02 typing by flow cytometry
  • Mutation/biomarker tested patient samples
  • PD-L1, MSI, MMR, BRAF, EGFR, KRAS, and NRAS
PBMCs
  • Cell counts and viability using AOPI staining
  • Pathology report and clinical information
FFPE
  • Full FFPE block
  • Pathology report of confirmed diagnoses
  • Patient and sample data including age, race, gender, resection date, tumor percentage, etc.

BMMC Matched Sets

AML BMMCs
  • Cell population analysis and HLA-A02 typing by flow cytometry
  • Pathology report with confirmation of diagnosis, donor demographic data, date of procedure, and medical information
  • Patient demographic characterization like cell count, viability, age, sex, ethnicity, height/weight, smoking status, alcohol history, etc.
PBMCs
  • Cell counts and viability using AOPI staining
  • Pathology report and clinical information
MM BMMCs
  • Cell population analysis and HLA-A02 typing by flow cytometry
  • Pathology report with confirmation of diagnosis, donor demographic data, date of procedure, and medical information
  • Patient demographic characterization like cell count, viability, age, sex, ethnicity, height/weight, smoking status, alcohol history, etc.
PBMCs
  • Cell counts and viability using AOPI staining
  • Pathology report and clinical information

Need biomarker characterization
for your human blood
biospecimens? 

While our biospecimens are highly characterized, we also provide streamlined multi-omic biomarker analyses to further characterize biospecimens from our inventory or from your studies via our global CLIA certified service laboratories*.

Genomic Biomarkers

Image
  • HudsonAlpha Discovery
  • Whole Genome Sequencing
  • Whole Exam Sequencing
  • Targeting Panels
  • Hi-Fi Long Read Sequencing
  • RNASeq
  • Single Cell Sequencing

Tissue Biomarkers

Image
  • IHC
  • Multiplexed IF (mIF)
  • RNA Scope
  • Digital Pathology & Image Analysis
  • PCR
  • In-Situ Hybridization
  • Colorimetric

Cell Services

Image
  • Flow Cytometry
  • Dissociation & Isolation
  • Cell Culture & Expansion

*HudsonAlpha Discovery Sequencing and Bioinformatics laboratory is CLIA registered, pending CAP accreditation.

Learn More

Frequently Asked Questions

For FFPE + Plasma matched sets, when is the blood collected?
For FFPE + Plasma matched sets, blood is collected pre-surgical intervention.
What anticoagulant is used for FFPE + Plasma sets?
EDTA is used for FFPE + Plasma sets.
How quickly is the plasma processed post blood collection?
Plasma is processed within 2 hours after the blood is collected

To propel your projects with The Power of Discovery.™

Contact Us Today

Let us know about your project!

Image